ClinicalTrials.Veeva

Menu

Quercetin in the Prevention of Covid-19 Infection

A

Azienda di Servizi alla Persona di Pavia

Status

Completed

Conditions

Covid19

Treatments

Dietary Supplement: Quercetin
Combination Product: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05037240
1222/01022021

Details and patient eligibility

About

Quercetin is a flavonol, a subclass of flavonoid compounds. Of the flavonol molecules, quercetin is the most abundant in fruit and vegetables. Quercetin flavonol is characterized by 3 crucial properties: antioxidant, anti-inflammatory and immunomodulatory. The combination of these 3 properties makes quercetin an excellent candidate for dealing with situations in which oxidative stress, inflammation and the immune system are involved. The purpose of the study is to evaluate the effectiveness of an oral nutritional supplement based on quercetin in the prevention of Covid-19 infection.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Absence of Covid-19 infection

Exclusion criteria

  • Previous Sars-Cov-2 infection demonstrated with antibody positivity through venous sampling
  • Demonstrated presence of Sars-Cov-2 through a nasopharyngeal antigenic swab before the start of oral nutritional supplementation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups, including a placebo group

Intervention Group
Active Comparator group
Treatment:
Dietary Supplement: Quercetin
Placebo
Placebo Comparator group
Treatment:
Combination Product: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems